Marketing authorization for the first EU vaccine to protect adolescents against chikungunya has been expedited for its public health interest.
In its first meeting of 2025, the Europe an Medicines Agency Committee for Medicinal Products for Human Use gave the green light for the first vaccine in the EU to protect adolescents from the age of 12 years and up against the viral disease chikungunya.
Since 2004, outbreaks of CHIKV have become more frequent and widespread. This has been partly due to viral adaptations allowing the virus to spread more easily viaof chikungunya and more than 200 deaths were reported worldwide. CHIKV infections affect people mostly in the tropics and subtropics. There is no specific antiviral drug treatment for CHIKV infections. Clinical management includes treatment of fever and joint pain, sufficient fluid intake, and rest. Most patients recover fully from the infection, however occasional cases of eye, heart, and neurological complications have been reported.
Tropical Disease Vaccine Vaccines Adolescent Medicine Teens Teenage Teenager Adolescent Health Adolescents Adolescent Europe European Arthralgia Painful Joint Joint Pain Pain Pain Management Myalgia Muscle Pain Chikungunya Virus Chikungunya Fever CHIKF Fever Pyrexia Febrile Response Dengue Dengue Fever Antiviral Famciclovir Valacyclovir Immunizations
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
The Long-Term Impact of Sleep on Adolescent Mental HealthThis article explores the connection between childhood sleep patterns and adolescent mental health. Longitudinal research conducted by the authors reveals that better sleep in early adolescence is linked to fewer mental health issues later on. The findings highlight the importance of sleep for healthy development and suggest that interventions aimed at improving sleep hygiene could have long-term benefits for adolescents' mental well-being.
Read more »
Adolescent Trauma Outcomes Similar at Pediatric and Adult CentersAdolescent trauma care at pediatric and adult centers showed no significant difference in mortality rates, suggesting that both settings are equally safe for managing severe injuries.
Read more »
Dogecoin's Price Action at 26 EMA: Three Possible ScenariosDogecoin is currently testing the 26 EMA resistance level, a crucial point for its future price movement. This article explores three potential scenarios based on how DOGE interacts with this resistance: a breakout, a rejection, or a sideways movement. Each scenario outlines its implications for the price, including potential target ranges and market sentiment.
Read more »
EUR/USD Dips Below 100-Day EMA; Bearish Outlook PersistsThe EUR/USD pair weakens on Monday, trading near 1.0315. The anticipation of further ECB interest rate cuts weighs on the Euro. Technical indicators suggest a bearish bias, with the pair trading below the 100-day EMA and RSI indicating downward momentum.
Read more »
GBP/JPY Dumps Another 0.6%, Tests 200 EMAGBP/JPY continues its downward trend, testing the 200-day exponential moving average (EMA) and reaching its lowest point in nearly a month. Economic data remains limited, with key events like UK inflation and consumer activity figures expected next week.
Read more »
2 years later, former EMA director remembers Autauga County tornado that claimed 7 livesThe former EMA director says the emotions from that day hit even harder as time goes by.
Read more »